Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ask a Friend to Take a Test for Hepatitis C Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03697135
Recruitment Status : Enrolling by invitation
First Posted : October 5, 2018
Last Update Posted : October 22, 2018
Sponsor:
Collaborator:
University of Dundee
Information provided by (Responsible Party):
NHS Tayside

Brief Summary:
This exploratory study will carry out a respondent-driven sampling exercise, where participants will identify their previous injecting partners and contact these individuals to invite them to take an Hepatitis C test. The data from participants about their injecting network will be used to construct a social network map (egonet) of the interlinking injecting networks. The numbers of individuals identified in the injecting networks will be used to estimate the size of the injecting population in Dundee. Participants will be interviewed to find out how they felt about the processes used.

Condition or disease Intervention/treatment
Hepatitis C Behavioral: Respondent Driven Sampling

  Show Detailed Description

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: A Respondent Driven Sampling Study to Identify the Hidden Population of Former Intravenous Drug Users With Hepatitis C Infection Who Are no Longer in Contact With Services. "Ask a Friend"
Actual Study Start Date : September 1, 2018
Estimated Primary Completion Date : March 31, 2019
Estimated Study Completion Date : March 31, 2019

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Seed Contacts
Initial participants who will invite previous injecting contacts to take a hepatitis C test using a respondent driven sampling method
Behavioral: Respondent Driven Sampling
Participants are asked to invite contacts that they previously injected with to take a test for hepatitis C

Initial Nominations for Testing
Contacts of initial participants who consent to be tested and enrol in the study using a respondent driven sampling method
Behavioral: Respondent Driven Sampling
Participants are asked to invite contacts that they previously injected with to take a test for hepatitis C

Second Level Nominations for testing
Contacts of wave one participants who consent to be tested and enrol in the study using a respondent driven sampling method
Behavioral: Respondent Driven Sampling
Participants are asked to invite contacts that they previously injected with to take a test for hepatitis C




Primary Outcome Measures :
  1. Hepatitis C test [ Time Frame: baseline ]
    Number of participants consenting to a Hepatitis C test by Dried Blood Spot


Secondary Outcome Measures :
  1. Process evaluation [ Time Frame: baseline ]
    Qualitative interview with each participant using discussion guide agreed by ethics



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Injecting partners of people who use drugs
Criteria

Inclusion criteria for the study are as follows:

  • Previous or current history of injecting drug use
  • Able to provide informed consent
  • Willing to identify previous injecting partners (people they have injected with)
  • Willing to undergo training on approaching previous injecting partners according to the study proceduresWilling to contact previous injecting partners according to the study proceduresAged 18 and over

Exclusion criteria for the study are as follows:

  • No previous history of injecting drug use
  • Not willing to provide informed consentNot willing to participate in the procedures required in the study protocol.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03697135


Locations
Layout table for location information
United Kingdom
Ninewells Hospital
Dundee, Tayside, United Kingdom, DD1 9SY
Sponsors and Collaborators
NHS Tayside
University of Dundee
Investigators
Layout table for investigator information
Study Director: John Dillon, MD University of Dundee

Publications:
Layout table for additonal information
Responsible Party: NHS Tayside
ClinicalTrials.gov Identifier: NCT03697135     History of Changes
Other Study ID Numbers: 2016GA02
First Posted: October 5, 2018    Key Record Dates
Last Update Posted: October 22, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Anonymised social network structures of a hepatitis C injecting network

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Hepatitis
Hepatitis A
Hepatitis C
Hepatitis, Viral, Human
Liver Diseases
Digestive System Diseases
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections